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Abstract Systemic lupus erythematosus (SLE) is an auto-
immune disease associated with an increased risk of throm-
bosis. We hypothesized that inflammation-associated
hyperfibrinogenemia can contribute to the prothrombotic
phenotype of fibrin clots by changing their mechanical
properties. Twenty-eight SLE patients were categorized
based on their disease activity scores (SLEDAI) into the
groups with inactive (SLEDAI < 4, n = 14) and active
(SLEDAI > 4, n = 14) forms of the disease. Clots from
individual platelet-free plasma samples were probed using
shear rheometry and viscoelastic properties of the fibrin
gels were determined as the storage (G′) and loss (G″) mod-
uli. A significant increase of G′ was revealed in the clots
from the plasma of active SLE patients over inactive SLE,
which correlated with elevated fibrinogen levels. Clots
from the plasma of inactive SLE patients had the elasticity
and fibrinogen levels indistinguishable from those in con-
trol plasma from healthy subjects. Thus, inflammatory
hyperfibrinogenemia in the active SLE form makes fibrin
clots stiffer which has been previously shown to be associ-
ated with a higher incidence of thrombotic disorders.
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1 Introduction
In systemic lupus erythematosus (SLE), a multiorgan autoim-
mune disease, thrombosis makes an important contribution to
mortality and long-term morbidity [1]. Although thrombotic
complications are relatively common in SLE, mechanisms un-
derlying the SLE-related thrombophilia remain unclear. A net-
work of fibrin fibers is a major component of hemostatic blood
clots and obstructive thrombi, which is responsible for their
mechanical strength, integrity, and deformability in a highly
dynamic environment of flowing blood [2]. Abnormal me-
chanical properties of fibrin clots have been shown to be asso-
ciated with a higher risk of thrombosis and thromboembolism
[3]. Clot mechanics depend strongly on the variable structure
of fibrin that is largely determined by many environmental
factors, including a level of fibrinogen, the soluble fibrin
precursor in blood [4]. Because fibrinogen is an acute-phase
protein that is up-regulated in response to inflammation [5], it
is likely to be a pathogenic modulator of the structure and
mechanical properties of clots and thrombi. All these provide
a rationale for studies on the link between fibrinogen levels in
blood, rheological properties of blood clots, and predisposition
to thrombosis in SLE. Here we investigated the mechanical
features of fibrin clots and their association with fibrinogen
levels in SLE patients with respect to the disease activity.
2 Material and Methods
The study was approved by the Ethical Committee of Kazan
State Medical University. Twenty-eight consecutive patients
who met the revised criteria for SLE of the American College
of Rheumatology [6] were enrolled in the study. Twenty-three
(82%) of them were females and the mean age of the patients
was 37 ± 13 years. The control group comprised 10 age- and
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